瑞安建業(00983.HK)附屬擬3700萬港元收購衞寶科技65%股權
格隆匯12月20日丨瑞安建業(00983.HK)公吿,於2021年12月20日,買方盛貿機電有限公司(為公司的間接非全資附屬公司)與賣方鍾健華先生訂立買賣協議,買方同意收購目標公司衞寶科技有限公司已發行股本的65%,代價為3,700萬港元(可予下調)。
目標公司主要於香港提供多媒體顯示系統、安防系統、專業紅外測温糸統、專業影音系統、門禁系統、排隊系統及相關服務以及維護服務。
集團一直積極物色有利於其長遠發展的投資機遇。收購事項將為集團提供擴闊收入來源的機會。鑑於目標公司的業務性質,預期於收購事項後集團的建築業務將與目標公司的業務產生協同效益,為集團帶來更多收益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.